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1. Introduction 
Galactosyltransferase ctivities have been described 
in various biological fluids [1-5] and more recently 
in human cancer sera [6], but to our knowledge not 
yet in cancerous ascitic fluids. So we have undertaken 
to investigate the galactosyltransferase activity of 
ascitic fluids towards endogenous and exogenous 
acceptors, and comparatively i n sera from the Balb/c 
mouse strain bearing the ascitic transplantable isogenic 
tumor YC8, a lymphoma which possesses at least two 
tumor membrane antigens [7]. On the other hand, 
Bosmann and Hilf [8] suggest that during neoplastic 
growth and tumor invasion, enzymes could diffuse 
from the tumor site towards the host fluids. If so, 
their soluble, non-membraneous nature could make 
their isolation and characterization easier. 
For this study a chromatographic method of deter- 
mining galactosyltransferase activity was applied [9] 
using ovomucoid as exogenous acceptor. This glyco- 
protein appeared in our experiments a the best 
galactose acceptor. It contains five N-acetylglucos- 
amino residues in non-reducing terminal positions [10]. 
2. Materials and methods 
2.1. Preparation o f  ovomucoid 
Ovomucoid was prepared as described by Jakubczak 
and Montreuil [ 11 ]. UDP- [14C] galactose (specific 
activity 274 mCi/mM) was purchased from New England 
Nuclear Corporation. Radioactivity was counted on 
• paper (see section 2.3) in a toluene PPO-POPOP 
(PPO 5 g, POPOP 0.5 g, Toluene 1 litre) scintillant 
liquid using Mark I and Intertechnique SIA0 liquid 
scintillation counters. 
2.2. Preparation o f  tumor cell suspensions 
A strain of YC8 ascite cells was carried in adult 
Balb/c mice following intraperitoneal injections of 
1.0 ml suspension containing 1to 3 × 10 s cells. Cell 
suspensions were harvested weekly. Sera from ascitic 
mice and from normal Balb/c mice were collected. 
Normal iquid peritoneal f uid was obtained from 
standard animals. Cells suspensions were centrifuged 
at 700 g at 4°C to separate cells and ascitic fluids. 
Ascitic fluids were further centrifuged (20 000 × g) 
to remove cellular debris. 
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2.3. Measurement o f  enzyme activity 
The complete reaction mixture consisted of 10/~1 
of biological fluid (ascitic fluid, peritoneal fluid or 
sera) containing 50/.tg of protein, 10/al of 1 M Tris 
buffer 7.2, 5/al of 0.4 M MnC12, 10/al of ovomucoid 
solution as exogenous acceptor (400/ag), 5 gl of 
UDP-[14C] galactose solution (61 pM and 16.8 nCi). 
Incubations were carried out at 37°C for 60 min. The 
reaction was stopped quickly in an ice-bath by the 
addition of 10 #1 of 0.2 M EDTA. Aliquots of each 
incubation mixture were applied to Whatman No 3 
paper sheets and submitted to descending chromato- 
graphy during 18 h in ethyl acetate/pyridine/acetic 
acid/water (5:5:1:3; v/v/v/v) according to Spik et al. 
[9]. In this chromatographic system, the radioactivity 
of the compound remaining at the origin represents 
the amount of [14C] galactose incorporated in the 
endogenous or exogenous glycoprotein acceptors. 
2.4. General methods 
Proteins were determined by a modification of the 
Lowry method with crystalline bovine albumin as 
standard [12,13]. 
3. Results and discussion 
Protein amounts were 35 +-- 4 mg/ml in ascitic fluid, 
2 -+ 1 mg/ml in normal peritoneal f uids, 51 +- 5 mg/ml 
in sera from ascitic mice, and 68 -+ 4 mg/ml in normal 
sera. These results show a hypoproteinemia in sera 
from ascitic mice. 
In preliminary experiments, we have defined some 
requirements for galactose transfer in YC8 ascitic 
fluids and sera; the results we obtained are described 
in table 1. The enzyme shows a requirement for Mn 2÷ 
which cannot be replaced by Mg 2÷ either in ascitic 
fluid or in sera. Its activity is greater at 37°C than at 
20°C. Optimal pH values for activity are: enzyme from 
ascitic fluid 6.3 and 7.0; from normal and ascitic sera 
6.3 and 7.2 (fig.l). More significant is the decreased 
activity at pH 6.5 for the ascitic fluid enzyme as com- 
pared to pH 7.0 for the serum enzyme. All these 
values are reproducible and similar results have been 
recently obtained by Podolsky and Weiser [6] with 
normal human and cancerous sera. 
In table 1 are reported the exogenous (transfer to 
ovomucoid) glycoprotein-galactosyltransferase activi-
ties of YC8 mice ascitic fluid and sera, on the one hand, 
and of normal mouse peritoneal fluid and sera, on the 
other hand. There is a high galactosyltransferase ctivity 
in the ascitic fluid as compared to normal peritoneal 
fluid. In.a similar manner, galactosyltransferase ctivity 
is greater in sera from ascitic mice than from normal 
mice. 
The effect of ovomucoid concentration is shown 
in fig.2: the apparent K m values for ovomucoid are 
1.80 × 10 -s M for the ascitic fluid enzyme and 
2.92 × 10 -5 M for the normal sera enzyme. An inter- 
mediate value of 2.53 X 10 -s was found for the ascitic 
Table 1 
Exogenous glycoprotein-galactosyltransferase activities a in ascitic fluids and 
sera from Balb/c-YC8 mice 
Incubation mixture Activity [ 14C] Gal transferred 
(%) in (pmol/mg protein/b) X 102 
Ascitic fluid, complete mixture 100 94 600 
Minus ascitic fluid 0.15 142 
Minus Mn 2÷ 1.5 1418 
Minus Mn 2÷, plus Mg 2÷ 2.1 1986 
Peritoneal fluid %8 7378 
Serum from ascitic mice complete mixture 100 65 600 
Minus serum 0.15 98 
Minus Mn 2÷ 1.0 656 
Minus Mn 2+, plus Mg 2÷ 1.0 656 
Normal serum 79.9 52 400 
aOvomucoid used as acceptor 
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Fig. 1. Effect of pH on the galactosyltransferase ctivity in 
ascitic fluid (o), sera from ascitic mice (o) and sera from 
normal mice (e). Incubation conditions are described in 
Materials and methods. 
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Fig. 2. Lineweaver-Burk plot of the galactosyltransferase 
activity for ovomucoid by ascitic fluid (o), sera from ascitic 
mice (o) and sera from normal mice (e). Incubation conditions 
are described in Materials and methods. Reciprocal values of 
activity are plotted versus reciprocal values of ovomucoid 
concentration. 
galactosyltransferase ctivities (table 2) reveals triking 
and evcn more significant differences: enzymatic 
activity is 80-fold higher in ascitic fluid than in 
normal peritoneal fluid, and 6-fold higher in YCo8 
mice sera than in normal mice sera. 
mice sera. The apparent K m values for UDP-galactose 
are not  significantly different: 1.49, 1.49 and 1.79 
(all X 10 -s M) for ascitic fluid, ascitic sera and normal 
sera, respectively. 
The determination of  endogenous glycoprote in -  
4. Conclusion 
The determination of  galactosyl transfer activity in 
presence or absence of  ovomucoid leads us to the 
demonstration of an important glycoprotein-galactosyl-  
transferase activity towards exogenous and endogenous 
Table 2 
Transfer of galactose to endogenous acceptors in ascitic fluids and 
sera from ascitic and normal mice 
Enzyme from [ ~4C]Gal transferred 
in c.p.m./mg protein/h 
[ '4C] Gal transferred 
in (pmol/mg protein/h) × 102 
Normal mice sera 232 +- 12 
Ascitic mice sera 1396 +- 84 
Normal peritoneal f uid 41 -+ 14 
Ascitic fluid 3244 -+ 136 
70.4 
424 
12.5 
984 
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acceptors, in ascitic fluid and in sera from Balb/c-YC8 
mice. 
The data suggest that the galactosyltransferase of 
ascitic fluid is different from that of normal sera: the 
activity as a function of pH and the K m values for 
ovomucoid are significantly different. On the other 
hand, the fact that these parameters are intermediate in
the case of the YC-8 mice sera suggest that the ascitic 
fluid enzyme diffuses from the ascite towards the 
blood plasma. 
The elevated level of galactosyltransferase ctivity 
in the ascitic fluid of Balb/c-YC8 mice suggests a 
diffusion of the enzyme from the cancerous cells to 
the ascitic fluid, thus supporting the hypothesis of 
Bosmann and Hilf [8]. However we cannot eliminate, 
on the one hand, the possibility of the appearance or 
the increase of enzymic activities, and on the other 
hand, the appearance of galactosyl-acceptor entities 
produced by the animal itself in reaction against he 
tumor. Experiments are now underway to determine 
the origin of these enzymes and the mechanism of 
their diffusion. 
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